Abstract
Graphene and graphene oxide (GO), due to their physicochemical properties and biocompatibility, can be used as an innovative biomedical material in biodetection, drug distribution in the body, treating neoplasms, regenerative medicine, and in implant surgery. Research on the biomedical use of graphene and GO that has been carried out until now is very promising and shows that carbon nanomaterials present high biocompatibility. However, the intolerance of the immune system to graphene nanomaterials, however low, may in consequence make it impossible to use them in medicine. This paper shows the specific mechanism of the molecular influence of graphene and GO on macrophages and lymphocytes under in vitro and in vivo conditions and their practical application in medicine. Under in vitro conditions graphene and GO cause an increased production of pro-inflammatory cytokines, mainly IL-1, IL-6, IL-10 and TNF-α, as a result of the activation of Toll-like receptors in macrophages. Graphene activates apoptosis in macrophages through the TGFbr/Smad/Bcl-2 pathway and also through JNK kinases that are stimulated by an increase of ROS in the cell or through a signal received by Smad proteins. Under in vivo conditions, graphene nanomaterials induce the development of the local inflammatory reaction and the development of granulomas in parenchymal organs. However, there is a huge discrepancy between the results obtained by different research groups, which requires a detailed analysis. In this work we decided to collect and analyze existing research and tried to explain the discrepancies. Understanding the precise mechanism of how this nanomaterial influences immune system cells allows estimating the potential influence of grapheme and GO on the human body.
Similar content being viewed by others
References
Andersen PS, Menné C, Mariuzza RA et al (2001) A response calculus for immobilized T cell receptor ligands. J Biol Chem 276:49125–49132
Bai JW, Zhong X, Jiang S et al (2010) Graphene nanomesh. Nat Nanotechnol 5:190–194
Balandin AA, Ghosh S, Bao W et al (2008) Superior thermal conductivity of single-layer graphene. Nano Lett 8:902–907
Bao HQ, Pan YZ, Ping Y et al (2011) Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small 7:1569–1578
Beek JJ, Wimmers F, Hato SV et al (2014) Dendritic cell cross talk with innate and innate-like effector cells in antitumor immunity: implications for DC vaccination. Crit Rev Immunol 34:517–536for drug and gene delivery. Small 7:1569–1578
Bianco A, Kostarelos K, Prato M (2011) Making carbon nanotubes biocompatible and biodegradable. Chem Commun 47:10182–10188
Billiau P, Matthys P (2009) Interferon-gamma: a historical perspective. Cytokine Growth Factor Rev 20:97–113
Bitounis D, Ali-Boucetta H, Hee B et al (2013) Prospects and challenges of graphene in biomedical applications. Adv Mater 25:2258–2268
Bolotin KI, Sikes KJ, Jiang Z (2008) Ultrahigh electron mobility in suspended graphene. State Commun 146:351–355
Bussy C, Ali-Boucetta H, Kostarelos K (2012) Safety considerations for graphene: lessons learnt from carbon nanotubes. Acc Chem Res 46:692–701
Cai W, Zhu Z, Li X (2009) Large area few-layer graphene/graphite films as transparent thin conducting electrodes. Phys Lett 95:123115
Cargnello M, Roux PP (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75:50–83
Chang CK, Wu JS, Mao D et al (2002) Mechanical and histological evaluations of hydroxyapatite coated dnd noncoated TiA14V implants in tibia bone. J Biomed Mater Res 56:17–23
Chang Y, Yang ST, Liu JH (2011) In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicol Lett 200:201–210
Chatterjee N, Eom HJ, Choi J (2014) A systems toxicology approach to the surface functionality control of graphene cell interaction. Biomaterials 35:1109–1127
Chen B, Liu M, Zhang LM et al (2011) Polyethylenimine-functionalized graphene oxide as an efficient gene delivery vector. J Mater Chem 21:7736–7741
Chen GY, Yang H, Lu Ch et al (2012) Simultaneous induction of autophagy and toll-like receptor signaling pathways by graphene oxide. Biomaterials 33:6559–6569
Chen B, Liu L, Xu H et al (2015) Effectiveness of immune therapy combined with chemotherapy on the immune function and recurrence rate of cervical cancer. Exp Ther Med 9:1063–1067
Chipuk J, Bouchier-Hayes L, Green D (2006) Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell Death Differ 13:1396–1402
Chithrani BD, Chan WC (2007) Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett 7:1542–1550
Choe J, Obmolova G, Malia TJ et al (2005) Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain. Science 309:581–585
Chong Y, Ma Y, Shen H et al (2014) The in vitro and in vivo toxicity of graphene quantum dots. Biomaterials 19:5041–5048
Chung Ch, Kim YK, Shin D (2013) Biomedical applications of graphene and graphene oxide. Acc Chem Res 46:2211–2224
Coccini T, Roda E, Barni S et al (2013) Morphological and cytohistochemical evaluation of renal effects of cadmium-doped silica nanoparticles given intratracheally to rat. J Phys Conf Ser 429:1–8
Cortés I, Pérez-Camarero S, Del LJ et al (2013) Systematic review of economic evaluation analyses of available vaccines in Spain from 1990 to 2012. Vaccine 31:3473–3484
Cui D, Tian F, Ozkan CS (2005) Effect of single wall carbon nanotubes on human HEK293 cells. Toxicol Lett 155:73–85
Das S, Singh S, Singh V et al (2013) Oxygenated functional group density on graphene oxide: its effect on cell toxicity. Part Part Syst Charact 30:148–157
Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103:239–252
Devasagayam TP, Tilak JC, Boloor KK et al (2004) Free radicals and antioxidants in human health: current status and future prospect. J Assoc Physicians India 52:794–804
Dikin DA, Stankovich S, Zimney EJ (2007) Preparation and characterization of graphene oxide paper. Nature 448:457–460
Ding Z, Zhang Z, Ma H et al (2014) In vitro hemocompatibility and toxic mechanism of graphene oxide on human peripheral blood t lymphocytes and serum albumin. ACS Appl Mater Interfaces 6:19797–19807
Dobrovolskaia MA, Germolec DR, Weaver JL (2009) Evaluation of nanoparticle immunotoxicity. Nat Nanotechnol 4:411–414
Donaldson K, Stone V, Tran L et al (2004) Nanotoxicology. Occup Environ Med 61:727–728
Doyle S (2002) IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17:251–263
Dror-Ehre A, Mamane H, Belenkova T et al (2011) Graphene oxide: a nonspecific enhancer of cellular grow. ASCNANO 10:8100–8107
Duch MC, Budinger GR, Liang YT et al (2011) Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung. Nano Lett 11:5201–5207
Dudley ME, Rosenberg SA (2003) Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat Rev Cancer 3:666–675
Dutta D, Sundaram SK, Teeguarden JG et al (2007) Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol Sci 100:303–315
Erickson K, Erni R, Lee Z (2010) Determination of the local chemical structures of graphen oxide and reduce graphene oxide. Adv Mater 22:4467–4472
Fadel TR, Fahmy TM (2014) Immunotherapy applications of carbon nanotubes: from design to safe applications. Trends Biotechnol 32:198–209
Fadel TR, Sharp FA, Vudattu N et al (2014) A carbon nanotube–polymer composite for T-cell therapy. Nat Nanotechnol 9:639–647
Feng LZ, Liu Z (2011) Graphene in biomedicine: opportunities and challenges. Nanomedicine 6:317–324
Foged C, Brodin B, Frokjaer S et al (2005) Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm 298:315–322
Gao N, Zhang Q, Mu Q et al (2011) Steering carbon nanotubes to scavenger receptor recognition by nanotube surface chemistry modification partially alleviates NFkappaB activation and reduces its immunotoxicity. ACS Nano 5:4581–4591
Geim AK, Novoselov KS (2007) The rise of graphene. Nat Mater 6:183–191
Geyer M, Pelka K, Latz E (2015) Synergistic activation of Toll-like receptor 8 by two RNA degradation products. Nat Struct Mol Biol 22:99–101
Ghavami S, Hashemi M, Ande SR et al (2009) Apoptosis and cancer: mutations within caspase genes. J Med Genet 46:497–510
González PA, Carreño LJ, Coombs D et al (2005) T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. Proc Natl Acad Sci USA 102:4824–4829
Hasan K, Sandberg MO, Nur O et al (2011) Polycation stabilization of graphene suspensions. Nanoscale Res Lett 6:493
Hejiang Z, Bo Z, Jiajia Z et al (2014) The inhibition of migration and invasion of cancer cells by graphene via the impairment of mitochondrial respiration. Biomaterials 35:1597–1607
Hengartner MO (2000) The biochemistry of apoptosis. Nature 407:770–776
Jain KK (2009) Role of nanobiotechnology in the development of personalized medicine. Nanomedicine 4:249–252
James MA (2001) Biological responses to materials. Annu Rev Mater Res 31:81–110
Jastrzębska A, Kurtycz P, Olszyna AR (2012) Recent advances in graphene family materials toxicity investigations. J Nanopart Res 14:1320
Jędrasiak U, Kępińska M (2011) Role of macrophages in immunological reactions of perinatal period. Nowa Pediatria 4:26–29
Jung T, Kamm W, Breitenbach A et al (2001) Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice. Pharm Res 18:352–360
Jurk M, Heil F, Vollmer J et al (2002) Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 3:499
Kanakia S, Toussaint JD, Chowdhury SM (2014) Dose ranging, expanded acute toxicity and safety pharmacology studies for intravenously administered functionalized graphene nanoparticle formulations. Biomaterials 25:7022–7031
Kapai NA, Anisimova NY, Kiselevskii MV et al (2011) Selective cytokine-inducing effects of low dose Echinacea. Bull Exp Biol Med 150:711–713
Kawai T, Akira S (2007) Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 13:460–469
Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11:373–384
Kim TH, Namgung R, Singha K et al (2011) Graphene oxide-polyethylenimine nanoconstruct as a gene delivery vector and bioimaging tool. Bioconjug Chem 22:2558–2567
Kochat V, Nath A, Sneha SE et al (2011) High contrast imaging and thickness determination of graphene with in-column secondary electron microscopy. J Appl Phys 110:1–5
Kroemer G, Galluzzi L, Brenner C (2007) Mitochondrial membrane permeabilization in cell death. Physiol Rev 87:99–163
Kulia T, Bosea S, Mishrab AK et al (2012) Chemical functionalization of graphene and its applications. Prog Mater Sci 57:1061–1105
Lacerda L, Biancob A, Pratoc M et al (2006) Carbon nanotubes as nanomedicines: from toxicology to pharmacology. Adv Drug Deliv Rev 58:1460–1470
Lacotte S, García A, Décossas M et al (2008) Interfacing functionalized carbon nanohorns with primary phagocytic cells. Adv Mater 20:2421–2426
Lallemand F, Mazars A, Prunier C et al (2001) Smad7 inhibits the survival nuclear factor kappa B and potentiates apoptosis in epithelial cells. Oncogene 20:879–884
Lam CW, James JT, McCluskey R et al (2004) Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 77:126–134
Lan RY, Selmi C, Gershwin ME (2008) The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2). J Autoimmun 31:7–12
Lauw FN, Caffrey DR, Golenbock DT et al (2005) Of mice and man: TLR11 (finally) finds profiling. Trends Immunol 26:509–511
Li D, Mueller MB, Gilje S (2008) Processable aqueous dispersions of graphene nanosheet. Nat Nanotechnol 3:101–105
Li Y, Liu Y, Fu Y et al (2012) The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways. Biomaterials 33:402–411
Li N, Zhang Q, Gao S et al (2013a) Three-dimensional graphene foam as abiocompatible and conductive scaffold for neural stemcells. Sci Rep 3:1604
Li Y, Yuan H, von dem Bussche A et al (2013b) Graphene microsheets enter cells through spontaneous membrane penetration at edge asperities and corner sites. Proc Natl Acad Sci USA 110:12295–12300
Liu Z, Robinson JT, Sun X et al (2008) PEGylated nano-graphene oxide for delivery of water insoluble cancer drugs. J Am Chem Soc 130:10876–10877
Liu K, Zhang JJ, Cheng FF (2011a) Green and facile synthesis of highly biocompatible graphene nanosheets and its application for cellular imaging and drug delivery. J Mater Chem 21:12034–12040
Liu S, Zeng TH, Hofmann M et al (2011b) Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress. ACS Nano 5:6971–6980
Liu Z, Robinson JT, Tabakman SM et al (2011c) Carbon materials for drug delivery and cancer therapy. Mat Today 14:316–323
Liu B, Zhang J, Liao J et al (2014) Aptamer-functionalized nanoparticles for drug delivery. J Biomed Nanotechnol 10:3189–3203
Lockshin RA, Zakeri Z (2001) Programmed cell death and apoptosis: origins of the theory. Nat Rev Mol Cell Biol 2:545–550
Lu CH, Yang HH, Zhu CL (2009) A graphene platform for sensing biomolecules. Angew Chem Int Ed Engl 48:4785–4787
Luo N, Ni D, Yue H (2015) Surface-engineered graphene navigate divergent biological outcomes toward macrophages. ACS Appl Mater Interfaces 7:5239–5247
Lutsiak ME, Kwon GS, Samuel J (2006) Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses. J Pharm Pharmacol 58:739–747
Majewska M, Szczepanik M (2006) [The role of Toll-like receptors (TLR) in innate and adaptive immune responses and their function in immune response regulation] (in Polish). Postepy Hig Med Dosw 60:52–63
Malek TR (2014) The biology of interleukin-2. Annu Rev Immunol 26:453–479
Malhotra S, Kovats S, Zhang W, Coggeshall KM (2009) B cell antigen receptor endocytosis and antigen presentation to T cells require Vav and dynamin. J Biol Chem 284:24088–24097
Mao HY, Laurent S, Chen W et al (2013) Graphene: promises, facts, opportunities, and challenges in nanomedicine. Chem Rev 113:3407–3424
Markovic ZM, Harhaji-Trajkovic LM, Todorovic-Markovic BM et al (2011) In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes. Biomaterials 32:1121–1129
Matsuo K, Koizumi H, Akashi M et al (2011) Intranasal immunization with poly(gamma-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunity. J Control Release 152:310–316
Misterka S, Paluch D, Zywicka B et al (1998) [Changes in the level of interleukin-1 beta and interleukin-6 after implantation of selected medical materials. Introductory report] (in Polish). Polim Med 28:15–24
Mondal J, Avijit R, Nikhil R et al (2014) Graphene-nanoparticle composites and their applications in energy, environmental and biomedical science. Rev Nanosci Nanotechnol 16:177–192
Morozov SV, Novoselov KS, Katsnelson MI et al (2008) Giant intrinsic carrier mobilities in graphene and its bilayer. Phys Rev Lett 100:016602
Nagasae M, Udagawa E, Schumacher HR et al (1990) Prolonged Inflammatory reactions induced by ceramic powders the rat pouch model. Nihon Seikeigeka Gakkai Zasshi 64:602–611
Nalwa HS (2014a) A special issue on reviews in biomedical applications of nanomaterials, tissue engineering, stem cells, bioimaging, and toxicity. J Biomed Nanotechnol 10:2421–2423
Nalwa HS (2014b) A special issue on reviews in nanomedicine, drug delivery and vaccine development. J Biomed Nanotechnol 10:1635–1640
Nanda SS, An SS, Yi DK (2015) Oxidative stress and antibacterial properties of a graphene oxide-cystamine nanohybrid. Int J Nanomedicine 10:549–556
Nemazee D, Gavin A, Hoebe K et al (2006) Immunology: toll-like receptors and antibody responses. Nature 441:E4
Ni G, Wang Y, Wu X et al (2012) Graphene oxide absorbed anti-IL10R antibodies enhance LPS induced immune responses in vitro and in vivo. Immunol Let 148:126–132
Nishiya T, DeFranco AL (2004) Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling proper ties of the Toll-like receptors. J Biol Chem 279:19008–19017
Noguchi T, Ishii K, Fukutomi H et al (2008) Requirement of reactive oxygen species-dependent activation of ASK1-p38 MAPK pathway for extracellular ATP-induced apoptosis in macrophage. J Biol Chem 283:7657–7665
Orecchioni M, Bedognetti D, Sgarrella F et al (2014) Impact of carbon nanotubes and graphene on immune cells. J Transl Med 12:138
Ozinsky A (2000) The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 97:13766–13771
Pardoll DM (2002) Spinning molecular immunology into successful immunotherapy. Nat Rev Immunol 2:227–238
Park S, An J, Jung I et al (2009) Colloidal suspensions of highly r educed graphene oxide in a wide variety of organic solvents. Nano Lett 9:1593–1597
Pescatori M, Bedognetti D, Venturelli E et al (2013) Functionalized carbon nanotubes as immunomodulator systems. Biomaterials 34:4395–4403
Pinto A, Inês C (2013) Graphene-based materials biocompatibility: a review. Colloids Surf B Biointerfaces 111:188–202
Porter AE, Gass M, Muller K et al (2007) Direct imaging of single-walled carbon nanotubes in cells. Nat Nanotechnol 2:713–717
Qu G, Liu S, Zhang S et al (2013) Graphene oxide induces Toll-like receptor 4 (TLR4)-dependent necrosis in macrophages. ACS Nano 7:5732–5745
Ramesh S, Wildey GM, Howe PH (2009) Transforming growth factor beta (TGF-beta)-apoptosis the rise and fall of bim. Cell Cycle 8:11–17
Rana VK, Choi MC, Kong JY et al (2011) Synthesis and drug-delivery behavior of chitosan-functionalized graphene oxide hybrid nanosheets. Macromol Mater Eng 296:131–140
Rashid H, Khandaker G, Booy R (2012) Vaccination and herd immunity: what more do we know? Curr Opin Infect Dis 25:243–249
Resende RR, Fonseca EA, Tonelli MP et al (2014) Scale/topography of substrates surface resembling extracellular matrix for tissue engineering. J Biomed Nanotechnol 10:1157–1193
Ribeiro AM, Souza O, Amaral AC et al (2013) Nanobiotechnological approaches to delivery of dna vaccine against fungal infection. J Biomed Nanotechnol 9:221–230
Rochefort A, Wuest JD (2009) Interaction of substituted aromatic compounds with graphene. Langmuir 25:210–215
Russier J, Ei Treoss, Scarsi A (2013) Evidencing the mask effect of graphene oxide: a comparative study on primary human and murine phagocytic cells. Nanoscale 5:11234–11247
Ryoo SR, Kim YK, Min DH (2010) Behaviors of NIH-3T3 fibroblasts on graphene/carbon nanotubes: proliferation, focal adhesion, and gene transfection studies. ACS Nano 4:6587–6598
Sanchez VC, Jachak A, Hurt RH et al (2011) Biological interactions of graphene-family nanomaterials; an interdisciplinary review. Chem Res Toxicol 25:15–34
Sasidharan A, Panchakarla LS, Sadanandan AR et al (2012) Hemocompatibility and macrophage response of pristine and functionalized graphene. Small 8:1251–1263
Sato T, Terai M, Tamura Y (2011) Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy. Immunol Res 51:170–182
Sawosz W, Jaworski S, Kutwin M et al (2014) Toxicity of pristine graphene in experiments in a chicken embryo model. Int J Nanomedicine 9:3913–3922
Schinwald A, Murphy F, Jones A et al (2012) Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties. ACS Nano 6:736–746
Schuster N, Krieglstein K (2002) Mechanisms of TGF-beta-mediated apoptosis. Cell Tissue Res 307:1–14
Seabra AB, Paula AJ, de Lima R et al (2014) Nanotoxicity of graphene and graphene oxide. Chem Res Toxicol 27:159–168
Sharma M, Schoop R, Suter A et al (2011) The potential use of Echinacea in acne: control of Propionibacterium acnes growth and inflammation. Phytother Res 25:517–521
Shas SA, Sanders S, White CM (2007) Evaluation of echinacea for the prevention and treatment of the common cold: a meta analysis. Lancet Infect Dis 7:473–480
Shay T, Jojic V, Zuk O et al (2013) Conservation and divergence in the transcriptional programs of the human and mouse immune systems. Proc Natl Acad Sci 110:2946–2951
Shen H, Zhang L, Liu M et al (2012) Biomedical applications of graphene. Theranostics 2:283–294
Singh S (2010) Nanomedicine-nanoscale drugs and delivery systems. J Nanosci Nanotechnol 10:7906–7918
Singh R, Nalwa HS (2011) Medical applications of nanoparticles in biological imaging, cell labeling, antimicrobial agents, and anticancer nanodrugs. J Biomed Nanotechnol 7:489–503
Skoda M, Dudek I, Jarosz A et al (2014) Graphene: one material, many possibilities application difficulties in biological systems. J Nanomat. doi:10.1155/2014/890246
Soldano C, Mahmood A, Dujardin E (2010) Production, properties and potential of graphene. Carbon 48:2127–2150
Song Q, Jiang Z, Li N (2014) Anti-inflammatory effects of three-dimensional graphene foams cultured with microglial cells. Biomaterials 35:6930–6940
Stalińska L, Ferenc T (2005) [The role of TGF-beta in cell cycle regulation] (in Polish). Postepy Hig Med Dosw 59:441–449
Steenblock ER, Wrzesinski SH, Flavell AR et al (2009) Antigen presentation on artificial acellular substrates: modular systems for flexible, adaptable immunotherapy. Expert Opin Biol Ther 9:451–464
Sun XM, Liu Z, Welsher K et al (2008) Nano-graphene oxide for cellular imaging and drug delivery. Nano Res 1:203–212
Tao Y, Ju E, Ren J et al (2014) Immunostimulatory oligonucleotides-loaded cationic graphene oxide with photothermally enhanced immunogenicity for photothermal/immune cancer therapy. Biomaterials 35:9963–9971
Tirado Y, Puig A, Alvarez N et al (2015) Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis. Hum Vaccin Immunother 11:657–661
Tkach AV, Yanamala N, Stanley S et al (2013) graphene oxide, but not fullerenes, targets immunoproteasomes and suppresses antigen presentation by dendritic cells. Small 9:1686–1690
Tu Q, Pang L, Chen Y et al (2014) Effects of surface charges of graphene oxide on neuronal outgrowth and branching. Analyst 139:105–115
Uto T, Akagi T, Yoshinaga K et al (2010) The induction of innate and adaptive immunity by biodegradable poly(gamma-glutamic acid)nanoparticles via a TLR4 and MyD88 signaling pathway. Biomaterials 32:5206–5212
Vinkler M, Bainová H, Bryjová A et al (2015) Characterisation of Toll-like receptors 4, 5 and 7 and their genetic variation in the grey partridge. Genetica 143:101–112
Wajant H (2007) Connection Map for Fas signaling pathway. STKE. doi:10.1126/stke.3802007tr1
Wang K, Ruan J, Song H et al (2010) Biocompatibility of graphene oxide. Nanoscale Res Lett 6:1–8
Wang Y, Li ZH, Wang J (2011) Graphene and graphene oxide: biofunctionalization and applications in biotechnology. Trends Biotechnol 29:205–212
Wang W, Lim Z, Duan J (2014) In vitro enhancement of dendritic cell-mediated anti-glioma immune response by graphene oxide. Nanoscale Res Lett 9:311
Wei Y, Wang B, Wu J et al (2012) Bending rigidity and Gaussian bending stiffness of single-layered graphene. Nano Let 13:26–30
Wen ZS, Xu YL, Zou XT et al (2011) Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice. Mar Drugs 9:1038–1055
Xu WP, Zhang Ch, Li JP et al (2011) Facile synthesis of silver@graphene oxide nanocomposites and their enhanced antibacterial properties. J Mater Chem 21:4593–4597
Yang ZR, Wang HF, Zhao J et al (2007) Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy. Cancer Gene Ther 14:599–615
Yang XY, Zhang XY, Liu ZF (2008) High-efficiency loading and controlled release of doxorubicin hydrochloride on graphene oxide. J Phys Chem C 112:17554–17558
Yang K, Wan JM, Zhang AS et al (2011a) In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. ACS Nano 5:516–522
Yang XY, Wang YS, Huang X et al (2011b) Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity. J Mater Chem 21:3448–3454
Yang K, Gong H, Shi X et al (2013) In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration. Biomaterials 34:2787–2795
Yue H, Wei W, Yue Z (2012) The role of the lateral dimension of graphene oxide in the regulation of cellular responses. Biomaterials 33:4013–4021
Zaman M, Good MF, Toth I (2013) Nanovaccines and their mode of action. Methods 60:226–231
Zapała Ł, Lasek W (2007) Natural exogenous immunostimulators. Post Biol Kom 3:581–594
Zeinali M, Jammalan M, Ardestani SK et al (2009) Immunological and cytotoxicological characterization of tuberculin purified protein derivative (PPD) conjugated to single-walled carbon nanotubes. Immunol Lett 126:48–53
Zhang LM, Xia JG, Zhao QH et al (2010) Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 6:537–544
Zhang LM, Lu ZX, Zhao QH et al (2011a) Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI-grafted graphene oxide. Small 7:460–464
Zhang SA, Yang K, Feng LZ et al (2011b) In vitro and in vivo behaviors of dextran functionalized graphene. Carbon 49:4040–4049
Zhang G, Zeng X, Ping L (2013a) Nanomaterials in cancer-therapy drug delivery system. J Biomed Nanotechnol 9:741–750
Zhang H, Grüner G, Zhao Y (2013b) Recent advancements of graphene in biomedicine. J Mater Chem 1:2542–2567
Zhao Y, Xing G, Chai Z (2008) Nanotoxicology: are carbon nanotubes safe? Nat Nanotechnol 3:191–192
Zhi X, Fang H, Bao C et al (2013) The immunotoxicity of graphene oxides and the effect of PVP-coating. Biomaterials 34:5254–5261
Zhou H, Zhao K, Wei L et al (2012) The interactions between pristine graphene and macrophages and the production of cytokines/chemokines via TLR- and NF-kB-related signaling pathways. Biomaterials 33:6933–6942
Zhu BY, Murali S, Cai W et al (2010) Graphene and graphene oxide: synthesis, properties, and applications. Adv Mater 22:3906–3924
Zielinski A, Stefanoff P (2004) Herd immunity and effectiveness of vaccination. Przegl Epidemiol 58(Suppl 1):6–10
Zwiorek K, Bourquin C, Battiany J et al (2008) Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG oligonucleotides. Pharm Res 25:551–562
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Dudek, I., Skoda, M., Jarosz, A. et al. The Molecular Influence of Graphene and Graphene Oxide on the Immune System Under In Vitro and In Vivo Conditions. Arch. Immunol. Ther. Exp. 64, 195–215 (2016). https://doi.org/10.1007/s00005-015-0369-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00005-015-0369-3